Drug intelligence / Profile preview

Q-peptide

Development stage
Preclinical
Lead developer
Quthero
Modality
Peptides
Administration
Topical, Intravenous, Subcutaneous
01

Overview

Q-peptide is a proprietary synthetic peptide developed by Quthero, consisting of the seven-amino acid sequence QHREDGS derived from the fibrinogen-like domain of Angiopoietin-1. It acts as an agonist of the Angiopoietin-1 pathway, specifically targeting the Tie2 receptor to promote cell survival, angiogenesis, and tissue regeneration while reducing inflammation. Quthero is advancing the peptide for multiple regenerative medicine applications, including post-aesthetic procedure skin healing (to reduce redness and swelling), chronic wound regeneration, and cardiovascular indications such as myocardial infarction and peripheral artery disease. The peptide is designed to mimic the regenerative properties of the native Angiopoietin-1 protein in a more stable and deliverable format.

Other names
QHREDGS peptideAngiopoietin-1 mimetic peptideAngiopoietin1 mimetic peptideAngiopoietin 1 mimetic peptide
02

Targets

TEK (Tie2)

Beyond the preview

Go deeper on Q-peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q-peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call